{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:58:22Z","timestamp":1793422702931,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Several risk factors are associated with the chronic evolution of migraine. Clinical and preclinical studies have provided data about the role of hypertension (HT) as one of the potential modifiable risk factors of chronic migraine (CM). This review is focused on the biological and clinical evidence supporting common mechanisms underlying HT and migraine and the potential role of HT in the transition from episodic to chronic migraine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a narrative review from a literature search covering the available evidence from studies investigating: i) the role of HT in the transition to CM in clinical practice; ii) the biological mechanisms potentially underpinning the association between HT and evolution to CM; iii) the role of antihypertensive medications in migraine prophylaxis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>HT proved to be at the base of multiple mechanisms underlying migraine and migraine chronicization. Endothelial dysfunction, blood\u2013brain barrier alterations, calcitonin gene-related peptide signaling, and renin\u2013angiotensin\u2013aldosterone system dysregulation are involved in the worsening effect of HT on migraine frequency, and the role of HT in the transition to CM is supported by clinical observations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The observed evidence supports HT contribution to CM evolution due to shared pathophysiologic mechanisms. While a bidirectional influence appears to be ascertained, data are still lacking about the one-way role of HT as direct risk factor for CM transition. Further research is needed to confirm a causal role of HT in this process.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-024-01720-7","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:02:41Z","timestamp":1707091361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Arterial hypertension in the chronic evolution of migraine: bystander or risk factor? An overview"],"prefix":"10.1186","volume":"25","author":[{"given":"Federico","family":"Mazzacane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Vaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cotta Ramusino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Perini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"key":"1720_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/S-0038-1646946","volume":"38","author":"D Saylor","year":"2018","unstructured":"Saylor D, Steiner TJ (2018) The global burden of headache. Semin Neurol 38:182\u2013190. https:\/\/doi.org\/10.1055\/S-0038-1646946","journal-title":"Semin Neurol"},{"key":"1720_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP et al (2021) Migraine: epidemiology and systems of care. Lancet 397:1485\u20131495","journal-title":"Lancet"},{"key":"1720_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/J.NCL.2019.06.001","volume":"37","author":"RC Burch","year":"2019","unstructured":"Burch RC, Buse DC, Lipton RB (2019) Migraine: epidemiology, burden, and comorbidity. Neurol Clin 37:631\u2013649. https:\/\/doi.org\/10.1016\/J.NCL.2019.06.001","journal-title":"Neurol Clin"},{"key":"1720_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"J Olesen","year":"2018","unstructured":"Olesen J (2018) Headache Classification Committee of the International Headache Society (IHS) the international classification of headache disorders. Cephalalgia 38:1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"key":"1720_CR5","doi-asserted-by":"publisher","first-page":"464894","DOI":"10.3389\/FNEUR.2019.00629\/BIBTEX","volume":"10","author":"M Cotta Ramusino","year":"2019","unstructured":"Cotta Ramusino M, De Cillis I, Costa A, Antonaci F (2019) Impact of medical care on symptomatic drug consumption and quality of life in headache: a one-year population study. Front Neurol 10:464894. https:\/\/doi.org\/10.3389\/FNEUR.2019.00629\/BIBTEX","journal-title":"Front Neurol"},{"key":"1720_CR6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/J.1526-4610.2011.01945.X","volume":"51","author":"M Stokes","year":"2011","unstructured":"Stokes M, Becker WJ, Lipton RB et al (2011) Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache 51:1058\u20131077. https:\/\/doi.org\/10.1111\/J.1526-4610.2011.01945.X","journal-title":"Headache"},{"key":"1720_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/S10194-021-01252-4","volume":"22","author":"S Sacco","year":"2021","unstructured":"Sacco S, Lampl C, van den Maassen A et al (2021) Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine and Headache Alliance. J Headache Pain 22:39. https:\/\/doi.org\/10.1186\/S10194-021-01252-4","journal-title":"J Headache Pain"},{"key":"1720_CR8","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(20)32342-4","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Buse DC, Ashina H et al (2021) Migraine: integrated approaches to clinical management and emerging treatments. Lancet 397:1505\u20131518. https:\/\/doi.org\/10.1016\/S0140-6736(20)32342-4","journal-title":"Lancet"},{"key":"1720_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/01.WNL.0000325565.63526.D2","volume":"71","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Lipton RB (2008) Clinical course in migraine: conceptualizing migraine transformation. Neurology 71:848\u2013855. https:\/\/doi.org\/10.1212\/01.WNL.0000325565.63526.D2","journal-title":"Neurology"},{"key":"1720_CR10","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/S10194-012-0479-9","volume":"13","author":"S Ashina","year":"2012","unstructured":"Ashina S, Serrano D, Lipton RB et al (2012) Depression and risk of transformation of episodic to chronic migraine. J Headache Pain 13:615. https:\/\/doi.org\/10.1007\/S10194-012-0479-9","journal-title":"J Headache Pain"},{"key":"1720_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","volume":"84","author":"RB Lipton","year":"2015","unstructured":"Lipton RB, Fanning KM, Serrano D et al (2015) Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine. Neurology 84:688. https:\/\/doi.org\/10.1212\/WNL.0000000000001256","journal-title":"Neurology"},{"key":"1720_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1212\/01.WNL.0000252800.82704.62","volume":"68","author":"SJ Wang","year":"2007","unstructured":"Wang SJ, Fuh JL, Lu SR, Juang KD (2007) Outcomes and predictors of chronic daily headache in adolescents: a 2-year longitudinal study. Neurology 68:591\u2013596. https:\/\/doi.org\/10.1212\/01.WNL.0000252800.82704.62","journal-title":"Neurology"},{"key":"1720_CR13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1212\/01.WNL.0000113747.18760.D2","volume":"62","author":"Z Katsarava","year":"2004","unstructured":"Katsarava Z, Schneeweiss S, Kurth T et al (2004) Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 62:788\u2013790. https:\/\/doi.org\/10.1212\/01.WNL.0000113747.18760.D2","journal-title":"Neurology"},{"key":"1720_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1177\/0333102409357958","volume":"30","author":"S Ashina","year":"2010","unstructured":"Ashina S, Lyngberg A, Jensen R (2010) Headache characteristics and chronification of migraine and tension-type headache: a population-based study. Cephalalgia 30:943\u2013954. https:\/\/doi.org\/10.1177\/0333102409357958","journal-title":"Cephalalgia"},{"key":"1720_CR15","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/J.1526-4610.2008.01217.X","volume":"48","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Serrano D, Buse D et al (2008) Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 48:1157\u20131168. https:\/\/doi.org\/10.1111\/J.1526-4610.2008.01217.X","journal-title":"Headache"},{"key":"1720_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1046\/J.1468-2982.1987.0701015.X","volume":"7","author":"F Granella","year":"1987","unstructured":"Granella F, Farina S, Malferrari G, Manzoni GC (1987) Drug abuse in chronic headache: a clinico-epidemiologic study. Cephalalgia 7:15\u201319. https:\/\/doi.org\/10.1046\/J.1468-2982.1987.0701015.X","journal-title":"Cephalalgia"},{"key":"1720_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/0333102419883355","volume":"40","author":"J Xu","year":"2020","unstructured":"Xu J, Kong F, Buse DC (2020) Predictors of episodic migraine transformation to chronic migraine: a systematic review and meta-analysis of observational cohort studies. Cephalalgia 40:503\u2013516. https:\/\/doi.org\/10.1177\/0333102419883355","journal-title":"Cephalalgia"},{"key":"1720_CR18","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/HEAD.13459","volume":"59","author":"DC Buse","year":"2019","unstructured":"Buse DC, Greisman JD, Baigi K, Lipton RB (2019) Migraine progression: a systematic review. Headache 59:306\u2013338. https:\/\/doi.org\/10.1111\/HEAD.13459","journal-title":"Headache"},{"key":"1720_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/J.1526-4610.2007.00969.X","volume":"48","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Lipton RB (2008) Concepts and mechanisms of migraine chronification. Headache 48:7\u201315. https:\/\/doi.org\/10.1111\/J.1526-4610.2007.00969.X","journal-title":"Headache"},{"key":"1720_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1212\/WNL.0B013E3182A6CB72","volume":"81","author":"E Cernuda-Moroll\u00f3n","year":"2013","unstructured":"Cernuda-Moroll\u00f3n E, Larrosa D, Ram\u00f3n C et al (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81:1191\u20131196. https:\/\/doi.org\/10.1212\/WNL.0B013E3182A6CB72","journal-title":"Neurology"},{"key":"1720_CR21","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1111\/J.1755-5922.2010.00137.X","volume":"28","author":"TJ Kizhakekuttu","year":"2010","unstructured":"Kizhakekuttu TJ, Widlansky ME (2010) Natural antioxidants and hypertension: promise and challenges. Cardiovasc Ther 28:e20. https:\/\/doi.org\/10.1111\/J.1755-5922.2010.00137.X","journal-title":"Cardiovasc Ther"},{"key":"1720_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/S10072-017-2893-X\/TABLES\/2","volume":"38","author":"C Finocchi","year":"2017","unstructured":"Finocchi C, Sassos D (2017) Headache and arterial hypertension. Neurol Sci 38:67\u201372. https:\/\/doi.org\/10.1007\/S10072-017-2893-X\/TABLES\/2","journal-title":"Neurol Sci"},{"key":"1720_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12:455\u2013464. https:\/\/doi.org\/10.1038\/nrneurol.2016.93","journal-title":"Nat Rev Neurol"},{"key":"1720_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/NRNEUROL.2017.151","volume":"13","author":"DR Nyholt","year":"2017","unstructured":"Nyholt DR, Borsook D, Griffiths LR (2017) Migrainomics - identifying brain and genetic markers of migraine. Nat Rev Neurol 13:725\u2013741. https:\/\/doi.org\/10.1038\/NRNEUROL.2017.151","journal-title":"Nat Rev Neurol"},{"key":"1720_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/J.AUTNEU.2017.01.004","volume":"203","author":"L Babayan","year":"2017","unstructured":"Babayan L, Mamontov OV, Amelin AV et al (2017) Arterial hypertension in migraine: role of familial history and cardiovascular phenotype. Auton Neurosci 203:103\u2013107. https:\/\/doi.org\/10.1016\/J.AUTNEU.2017.01.004","journal-title":"Auton Neurosci"},{"key":"1720_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1586\/14737175.2014.946408","volume":"14","author":"P Ripa","year":"2014","unstructured":"Ripa P, Ornello R, Pistoia F et al (2014) The renin-angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis. Expert Rev Neurother 14:1043\u20131055. https:\/\/doi.org\/10.1586\/14737175.2014.946408","journal-title":"Expert Rev Neurother"},{"key":"1720_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3988\/jcn.2021.17.2.164","volume":"17","author":"M Paolucci","year":"2021","unstructured":"Paolucci M, Altamura C, Vernieri F (2021) The role of endothelial dysfunction in the pathophysiology and cerebrovascular effects of migraine: a narrative review. J Clin Neurol 17:164\u2013175","journal-title":"J Clin Neurol"},{"key":"1720_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1212\/01.WNL.0000197218.05284.82","volume":"66","author":"ME Bigal","year":"2006","unstructured":"Bigal ME, Liberman JN, Lipton RB (2006) Obesity and migraine: a population study. Neurology 66:545\u2013550. https:\/\/doi.org\/10.1212\/01.WNL.0000197218.05284.82","journal-title":"Neurology"},{"key":"1720_CR29","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1111\/J.1526-4610.2007.00719.X","volume":"47","author":"C Cavestro","year":"2007","unstructured":"Cavestro C, Rosatello A, Micca GM et al (2007) Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache 47:1436\u20131442. https:\/\/doi.org\/10.1111\/J.1526-4610.2007.00719.X","journal-title":"Headache"},{"key":"1720_CR30","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1212\/01.WNL.0000151857.43225.49","volume":"64","author":"AI Scher","year":"2005","unstructured":"Scher AI, Terwindt GM, Picavet HSJ et al (2005) Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64:614\u2013620. https:\/\/doi.org\/10.1212\/01.WNL.0000151857.43225.49","journal-title":"Neurology"},{"key":"1720_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/J.NEUROSCIENCE.2016.06.012","volume":"338","author":"B Jacobs","year":"2016","unstructured":"Jacobs B, Dussor G (2016) Neurovascular contributions to migraine: moving beyond vasodilation. Neuroscience 338:130\u2013144. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2016.06.012","journal-title":"Neuroscience"},{"key":"1720_CR32","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.116.302855","volume":"116","author":"G Eelen","year":"2015","unstructured":"Eelen G, De Zeeuw P, Simons M, Carmeliet P (2015) Endothelial cell metabolism in normal and diseased vasculature. Circ Res 116:1231\u20131244. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.302855","journal-title":"Circ Res"},{"key":"1720_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/J.CCC.2019.12.009","volume":"36","author":"AR Cyr","year":"2020","unstructured":"Cyr AR, Huckaby LV, Shiva SS, Zuckerbraun BS (2020) Nitric oxide and endothelial dysfunction. Crit Care Clin 36:307\u2013321. https:\/\/doi.org\/10.1016\/J.CCC.2019.12.009","journal-title":"Crit Care Clin"},{"key":"1720_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/S10194-019-1066-0","volume":"20","author":"AP Andreou","year":"2019","unstructured":"Andreou AP, Edvinsson L (2019) Mechanisms of migraine as a chronic evolutive condition. J Headache Pain 20:117","journal-title":"J Headache Pain"},{"key":"1720_CR35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1161\/01.CIR.0000112565.60887.1E","volume":"109","author":"EJ Benjamin","year":"2004","unstructured":"Benjamin EJ, Larson MG, Keyes MJ et al (2004) Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 109:613\u2013619. https:\/\/doi.org\/10.1161\/01.CIR.0000112565.60887.1E","journal-title":"Circulation"},{"key":"1720_CR36","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/J.1468-2982.2009.01937.X","volume":"29","author":"GE Tietjen","year":"2009","unstructured":"Tietjen GE (2009) Migraine as a systemic vasculopathy. Cephalalgia 29:987\u2013996. https:\/\/doi.org\/10.1111\/J.1468-2982.2009.01937.X","journal-title":"Cephalalgia"},{"key":"1720_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/S11916-018-0682-8","volume":"22","author":"A Iljazi","year":"2018","unstructured":"Iljazi A, Ayata C, Ashina M, Hougaard A (2018) The role of endothelin in the pathophysiology of migraine-a systematic review. Curr Pain Headache Rep 22:27","journal-title":"Curr Pain Headache Rep"},{"key":"1720_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/J.TCM.2013.12.001","volume":"24","author":"Y Higashi","year":"2014","unstructured":"Higashi Y, Maruhashi T, Noma K, Kihara Y (2014) Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications. Trends Cardiovasc Med 24:165\u2013169. https:\/\/doi.org\/10.1016\/J.TCM.2013.12.001","journal-title":"Trends Cardiovasc Med"},{"key":"1720_CR39","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJME020054","volume":"346","author":"JR Sowers","year":"2002","unstructured":"Sowers JR (2002) Hypertension, angiotensin II, and oxidative stress. N Engl J Med 346:1999\u20132001. https:\/\/doi.org\/10.1056\/NEJME020054","journal-title":"N Engl J Med"},{"key":"1720_CR40","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","volume":"87","author":"H Cai","year":"2000","unstructured":"Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840\u2013844. https:\/\/doi.org\/10.1161\/01.RES.87.10.840","journal-title":"Circ Res"},{"key":"1720_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/CBF.1785","volume":"29","author":"S Yildirim","year":"2011","unstructured":"Yildirim S, Akar S, Kuyucu M et al (2011) Paraoxonase 1 gene polymorphisms, paraoxonase\/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine. Cell Biochem Funct 29:549\u2013554. https:\/\/doi.org\/10.1002\/CBF.1785","journal-title":"Cell Biochem Funct"},{"key":"1720_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/S10194-023-01572-7","volume":"24","author":"AK Musubire","year":"2023","unstructured":"Musubire AK, Cheema S, Ray JC et al (2023) Cytokines in primary headache disorders: a systematic review and meta-analysis. J Headache Pain 24:36. https:\/\/doi.org\/10.1186\/S10194-023-01572-7","journal-title":"J Headache Pain"},{"key":"1720_CR43","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/0333102493013S1217","volume":"12","author":"NT Mathew","year":"1993","unstructured":"Mathew NT (1993) Transformed migraine. Cephalalgia 12:78\u201383. https:\/\/doi.org\/10.1177\/0333102493013S1217","journal-title":"Cephalalgia"},{"key":"1720_CR44","doi-asserted-by":"publisher","first-page":"640574","DOI":"10.3389\/FNHUM.2021.640574","volume":"15","author":"C Altamura","year":"2021","unstructured":"Altamura C, Corbelli I, de Tommaso M et al (2021) Pathophysiological bases of comorbidity in migraine. Front Hum Neurosci 15:640574. https:\/\/doi.org\/10.3389\/FNHUM.2021.640574","journal-title":"Front Hum Neurosci"},{"key":"1720_CR45","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/J.1468-2982.2005.00928.X","volume":"25","author":"I Rainero","year":"2005","unstructured":"Rainero I, Limone P, Ferrero M et al (2005) Insulin sensitivity is impaired in patients with migraine. Cephalalgia 25:593\u2013597. https:\/\/doi.org\/10.1111\/J.1468-2982.2005.00928.X","journal-title":"Cephalalgia"},{"key":"1720_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/ENE.12289","volume":"21","author":"A Fava","year":"2014","unstructured":"Fava A, Pirritano D, Consoli D et al (2014) Chronic migraine in women is associated with insulin resistance: a cross-sectional study. Eur J Neurol 21:267\u2013272. https:\/\/doi.org\/10.1111\/ENE.12289","journal-title":"Eur J Neurol"},{"key":"1720_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/S11154-012-9229-1","volume":"14","author":"R Muniyappa","year":"2013","unstructured":"Muniyappa R, Sowers JR (2013) Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord 14:5. https:\/\/doi.org\/10.1007\/S11154-012-9229-1","journal-title":"Rev Endocr Metab Disord"},{"key":"1720_CR48","doi-asserted-by":"publisher","first-page":"H813","DOI":"10.1152\/AJPHEART.00092.2005","volume":"289","author":"MA Potenza","year":"2005","unstructured":"Potenza MA, Marasciulo FL, Chieppa DM et al (2005) Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol 289:H813. https:\/\/doi.org\/10.1152\/AJPHEART.00092.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1720_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12883-022-02966-X\/TABLES\/5","volume":"22","author":"M Ali","year":"2022","unstructured":"Ali M, Hussein M, Magdy R et al (2022) The potential impact of insulin resistance and metabolic syndrome on migraine headache characteristics. BMC Neurol 22:1\u20138. https:\/\/doi.org\/10.1186\/S12883-022-02966-X\/TABLES\/5","journal-title":"BMC Neurol"},{"issue":"10","key":"1720_CR50","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41371-020-0352-2","volume":"34","author":"V Katsi","year":"2020","unstructured":"Katsi V, Marketou M, Maragkoudakis S et al (2020) Blood\u2013brain barrier dysfunction: the undervalued frontier of hypertension. J Hum Hypertens 34(10):682\u2013691. https:\/\/doi.org\/10.1038\/s41371-020-0352-2","journal-title":"J Hum Hypertens"},{"key":"1720_CR51","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01743","volume":"63","author":"VC Biancardi","year":"2014","unstructured":"Biancardi VC, Son SJ, Ahmadi S et al (2014) Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier. Hypertension 63:572\u2013579. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01743","journal-title":"Hypertension"},{"key":"1720_CR52","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1113\/EP086434","volume":"103","author":"A Setiadi","year":"2018","unstructured":"Setiadi A, Korim WS, Elsaafien K, Yao ST (2018) The role of the blood-brain barrier in hypertension. Exp Physiol 103:337\u2013342. https:\/\/doi.org\/10.1113\/EP086434","journal-title":"Exp Physiol"},{"key":"1720_CR53","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1172\/JCI21227","volume":"113","author":"Y Gursoy-Ozdemir","year":"2004","unstructured":"Gursoy-Ozdemir Y, Qiu J, Matsuoka N et al (2004) Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 113:1447\u20131455. https:\/\/doi.org\/10.1172\/JCI21227","journal-title":"J Clin Invest"},{"key":"1720_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/IBPC.S223341","volume":"13","author":"V Bisogni","year":"2020","unstructured":"Bisogni V, Cerasari A, Pucci G, Vaudo G (2020) Matrix metalloproteinases and hypertension-mediated organ damage: current insights. Integr Blood Press Control 13:157. https:\/\/doi.org\/10.2147\/IBPC.S223341","journal-title":"Integr Blood Press Control"},{"key":"1720_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S10194-021-01365-W","volume":"23","author":"A Wiggers","year":"2021","unstructured":"Wiggers A, Ashina H, Hadjikhani N et al (2021) (2022) Brain barriers and their potential role in migraine pathophysiology. Jo Headache Pain 23:1\u201310. https:\/\/doi.org\/10.1186\/S10194-021-01365-W","journal-title":"Jo Headache Pain"},{"key":"1720_CR56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/14728222.2020.1724285","volume":"24","author":"AS Wattiez","year":"2020","unstructured":"Wattiez AS, Sowers LP, Russo AF (2020) Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. Expert Opin Ther Targets 24:91\u2013100. https:\/\/doi.org\/10.1080\/14728222.2020.1724285","journal-title":"Expert Opin Ther Targets"},{"key":"1720_CR57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/BCP.12618","volume":"80","author":"L Edvinsson","year":"2015","unstructured":"Edvinsson L (2015) CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol 80:193\u2013199. https:\/\/doi.org\/10.1111\/BCP.12618","journal-title":"Br J Clin Pharmacol"},{"key":"1720_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/S11940-017-0463-4","volume":"19","author":"AR Tso","year":"2017","unstructured":"Tso AR, Goadsby PJ (2017) Anti-CGRP monoclonal antibodies: the next era of migraine prevention? Curr Treat Options Neurol 19:27","journal-title":"Curr Treat Options Neurol"},{"key":"1720_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0304-3940(91)90819-F","volume":"124","author":"M Nakamura-Craig","year":"1991","unstructured":"Nakamura-Craig M, Gill BK (1991) Effect of neurokinin A, substance P and calcitonin gene related peptide in peripheral hyperalgesia in the rat paw. Neurosci Lett 124:49\u201351. https:\/\/doi.org\/10.1016\/0304-3940(91)90819-F","journal-title":"Neurosci Lett"},{"key":"1720_CR60","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3389\/FPHYS.2018.01249","volume":"9","author":"Z Kee","year":"2018","unstructured":"Kee Z, Kodji X, Brain SD (2018) The role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic vasodilation and its cardioprotective effects. Front Physiol 9:1249. https:\/\/doi.org\/10.3389\/FPHYS.2018.01249","journal-title":"Front Physiol"},{"key":"1720_CR61","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/00004872-199210120-00010","volume":"10","author":"A Masuda","year":"1992","unstructured":"Masuda A, Shimamoto K, Mori Y et al (1992) Plasma calcitonin gene-related peptide levels in patients with various hypertensive diseases. J Hypertens 10:1499\u20131504. https:\/\/doi.org\/10.1097\/00004872-199210120-00010","journal-title":"J Hypertens"},{"key":"1720_CR62","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1097\/00004872-199210000-00017","volume":"10","author":"F Portaluppi","year":"1992","unstructured":"Portaluppi F, Trasformi G, Margutti A et al (1992) Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J Hypertens 10:1227\u20131234. https:\/\/doi.org\/10.1097\/00004872-199210000-00017","journal-title":"J Hypertens"},{"key":"1720_CR63","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1470320313503694\/ASSET\/IMAGES\/LARGE\/10.1177_1470320313503694-FIG3.JPEG","volume":"15","author":"A Bali","year":"2014","unstructured":"Bali A, Singh N, Jaggi AS (2014) Renin-angiotensin system in pain: existing in a double life? JRAAS. J Renin Angiotensin Aldosterone Syst 15:329\u2013340. https:\/\/doi.org\/10.1177\/1470320313503694\/ASSET\/IMAGES\/LARGE\/10.1177_1470320313503694-FIG3.JPEG","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"1720_CR64","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5049\/EBP.2008.6.1.42","volume":"6","author":"HE Yim","year":"2008","unstructured":"Yim HE, Yoo KH (2008) Renin-angiotensin system - considerations for hypertension and kidney. Electrolyte Blood Pressure 6:42. https:\/\/doi.org\/10.5049\/EBP.2008.6.1.42","journal-title":"Electrolyte Blood Pressure"},{"key":"1720_CR65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/DIAGNOSTICS13010016","volume":"13","author":"PJ Tomasik","year":"2022","unstructured":"Tomasik PJ, Bart NK, Adji AI et al (2022) A new perspective on the renin-angiotensin system. Diagnostics 13:16. https:\/\/doi.org\/10.3390\/DIAGNOSTICS13010016","journal-title":"Diagnostics"},{"key":"1720_CR66","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/HEAD.13949","volume":"60","author":"L Bhering Martins","year":"2020","unstructured":"Bhering Martins L, Silva de Miranda A, dos Rodrigues AM et al (2020) Altered serum levels of renin-angiotensin system markers in migraine. Headache 60:1995\u20132002. https:\/\/doi.org\/10.1111\/HEAD.13949","journal-title":"Headache"},{"key":"1720_CR67","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1046\/J.1526-4610.2001.041007629.X","volume":"41","author":"KMA Welch","year":"2001","unstructured":"Welch KMA, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629\u2013637. https:\/\/doi.org\/10.1046\/J.1526-4610.2001.041007629.X","journal-title":"Headache"},{"key":"1720_CR68","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1111\/CBDD.12049","volume":"80","author":"M Sharma","year":"2012","unstructured":"Sharma M, Garigipati S, Kundu B et al (2012) Discovery of novel 1,2,4-triazol-5-ones as tumor necrosis factor-alpha inhibitors for the treatment of neuropathic pain. Chem Biol Drug Des 80:961\u2013970. https:\/\/doi.org\/10.1111\/CBDD.12049","journal-title":"Chem Biol Drug Des"},{"key":"1720_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-7-27","author":"L Leung","year":"2010","unstructured":"Leung L, Cahill CM (2010) TNF-alpha and neuropathic pain\u2013a review. J Neuroinflammation. https:\/\/doi.org\/10.1186\/1742-2094-7-27","journal-title":"J Neuroinflammation"},{"key":"1720_CR70","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/J.1526-4610.2008.00852.X","volume":"48","author":"H Ba\u2019albaki","year":"2008","unstructured":"Ba\u2019albaki H, Rapoport A (2008) Mast cells activate the renin angiotensin system and contribute to migraine: a hypothesis. Headache 48:1499\u20131505. https:\/\/doi.org\/10.1111\/J.1526-4610.2008.00852.X","journal-title":"Headache"},{"key":"1720_CR71","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/MC.20710","volume":"50","author":"N Queisser","year":"2011","unstructured":"Queisser N, Oteiza PI, Stopper H et al (2011) Aldosterone induces oxidative stress, oxidative DNA damage and NF-\u03baB-activation in kidney tubule cells. Mol Carcinog 50:123\u2013135. https:\/\/doi.org\/10.1002\/MC.20710","journal-title":"Mol Carcinog"},{"key":"1720_CR72","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1345\/APH.1M312","volume":"44","author":"BJ Gales","year":"2010","unstructured":"Gales BJ, Bailey EK, Reed AN, Gales MA (2010) Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for the prevention of migraines. Ann Pharmacother 44:360\u2013366. https:\/\/doi.org\/10.1345\/APH.1M312","journal-title":"Ann Pharmacother"},{"key":"1720_CR73","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/J.1468-2982.2008.01825.X","volume":"29","author":"HC Diener","year":"2009","unstructured":"Diener HC, Gendolla A, Feuersenger A et al (2009) Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial. Cephalalgia 29:921\u2013927. https:\/\/doi.org\/10.1111\/J.1468-2982.2008.01825.X","journal-title":"Cephalalgia"},{"key":"1720_CR74","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/J.1468-1331.2007.01764.X","volume":"14","author":"S Schuh-Hofer","year":"2007","unstructured":"Schuh-Hofer S, Flach U, Meisel A et al (2007) Efficacy of lisinopril in migraine prophylaxis\u2013an open label study. Eur J Neurol 14:701\u2013703. https:\/\/doi.org\/10.1111\/J.1468-1331.2007.01764.X","journal-title":"Eur J Neurol"},{"key":"1720_CR75","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/0253-7613.93840","volume":"44","author":"R Nandha","year":"2012","unstructured":"Nandha R, Singh H (2012) Renin angiotensin system: a novel target for migraine prophylaxis. Indian J Pharmacol 44:157\u2013160. https:\/\/doi.org\/10.4103\/0253-7613.93840","journal-title":"Indian J Pharmacol"},{"key":"1720_CR76","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1046\/J.1526-4610.2003.03038.X","volume":"43","author":"R Camarda","year":"2003","unstructured":"Camarda R, Monastero R, Mannino M, Camarda C (2003) Enalapril prophylaxis for migraine with aura. Headache 43:170. https:\/\/doi.org\/10.1046\/J.1526-4610.2003.03038.X","journal-title":"Headache"},{"key":"1720_CR77","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/EURPUB\/CKT141","volume":"24","author":"AH Entonen","year":"2014","unstructured":"Entonen AH, Suominen SB, Korkeila K et al (2014) Migraine predicts hypertension\u2014a cohort study of the Finnish working-age population. Eur J Public Health 24:244\u2013248. https:\/\/doi.org\/10.1093\/EURPUB\/CKT141","journal-title":"Eur J Public Health"},{"key":"1720_CR78","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1212\/WNL.0B013E3181D0CC8B","volume":"74","author":"ME Bigal","year":"2010","unstructured":"Bigal ME, Kurth T, Santanello N et al (2010) Migraine and cardiovascular disease: a population-based study. Neurology 74:628\u2013635. https:\/\/doi.org\/10.1212\/WNL.0B013E3181D0CC8B","journal-title":"Neurology"},{"key":"1720_CR79","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1136\/JNNP.2009.192492","volume":"81","author":"DC Buse","year":"2010","unstructured":"Buse DC, Manack A, Serrano D et al (2010) Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81:428\u2013432. https:\/\/doi.org\/10.1136\/JNNP.2009.192492","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1720_CR80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-020-1084-y","volume":"21","author":"DC Buse","year":"2020","unstructured":"Buse DC, Reed ML, Fanning KM et al (2020) Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain 21:23","journal-title":"J Headache Pain"},{"key":"1720_CR81","doi-asserted-by":"publisher","first-page":"323","DOI":"10.18865\/ED.26.3.323","volume":"26","author":"H Gardener","year":"2016","unstructured":"Gardener H, Monteith T, Rundek T et al (2016) Hypertension and migraine in the Northern Manhattan Study. Ethn Dis 26:323\u2013330. https:\/\/doi.org\/10.18865\/ED.26.3.323","journal-title":"Ethn Dis"},{"key":"1720_CR82","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/J.MAYOCP.2023.01.010","volume":"98","author":"SS Faubion","year":"2023","unstructured":"Faubion SS, Smith T, Thielen J et al (2023) Association of migraine and vasomotor symptoms. Mayo Clin Proc 98:701\u2013712. https:\/\/doi.org\/10.1016\/J.MAYOCP.2023.01.010","journal-title":"Mayo Clin Proc"},{"key":"1720_CR83","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1177\/0333102418756865","volume":"38","author":"PM Rist","year":"2018","unstructured":"Rist PM, Winter AC, Buring JE et al (2018) Migraine and the risk of incident hypertension among women. Cephalalgia 38:1817. https:\/\/doi.org\/10.1177\/0333102418756865","journal-title":"Cephalalgia"},{"key":"1720_CR84","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1046\/J.1526-4610.2002.02143.X","volume":"42","author":"ME Bigal","year":"2002","unstructured":"Bigal ME, Sheftell FD, Rapoport AM et al (2002) Chronic daily headache: identification of factors associated with induction and transformation. Headache: The Journal of Head and Face. Pain 42:575\u2013581. https:\/\/doi.org\/10.1046\/J.1526-4610.2002.02143.X","journal-title":"Pain"},{"key":"1720_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/ENE.12794","volume":"23","author":"P Sarchielli","year":"2016","unstructured":"Sarchielli P, Corbelli I, Messina P et al (2016) Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study. Eur J Neurol 23:85\u201391. https:\/\/doi.org\/10.1111\/ENE.12794","journal-title":"Eur J Neurol"},{"key":"1720_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S10194-020-01111-8","volume":"21","author":"M Torres-Ferr\u00fas","year":"2020","unstructured":"Torres-Ferr\u00fas M, Ursitti F, Alpuente-Ruiz A et al (2020) From transformation to chronification of migraine: pathophysiological and clinical aspects. J Headache Pain 21:1\u201312. https:\/\/doi.org\/10.1186\/S10194-020-01111-8","journal-title":"J Headache Pain"},{"key":"1720_CR87","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/S10072-010-0322-5\/TABLES\/1","volume":"31","author":"S Gipponi","year":"2010","unstructured":"Gipponi S, Venturelli E, Rao R et al (2010) Hypertension is a factor associated with chronic daily headache. Neurol Sci 31:171\u2013173. https:\/\/doi.org\/10.1007\/S10072-010-0322-5\/TABLES\/1","journal-title":"Neurol Sci"},{"key":"1720_CR88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/S10072-012-1075-0\/TABLES\/1","volume":"33","author":"GC Manzoni","year":"2012","unstructured":"Manzoni GC, Lombardi LL, Lana S et al (2012) Detection of possible factors favouring the evolution of migraine without aura into chronic migraine. Neurol Sci 33:165\u2013167. https:\/\/doi.org\/10.1007\/S10072-012-1075-0\/TABLES\/1","journal-title":"Neurol Sci"},{"key":"1720_CR89","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/ENE.12547","volume":"22","author":"CF Fagern\u00e6s","year":"2015","unstructured":"Fagern\u00e6s CF, Heuch I, Zwart JA et al (2015) Blood pressure as a risk factor for headache and migraine: a prospective population-based study. Eur J Neurol 22:156-e11. https:\/\/doi.org\/10.1111\/ENE.12547","journal-title":"Eur J Neurol"},{"key":"1720_CR90","doi-asserted-by":"publisher","first-page":"221","DOI":"10.11607\/ofph.3174","volume":"36","author":"M Cotta Ramusino","year":"2022","unstructured":"Cotta Ramusino M, Perini G, Capelli M et al (2022) Potential contribution of hypertension to evolution of chronic migraine and related mechanisms. J Oral Facial Pain Headache 36:221\u2013228. https:\/\/doi.org\/10.11607\/ofph.3174","journal-title":"J Oral Facial Pain Headache"},{"key":"1720_CR91","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1161\/CIRCULATIONAHA.104.529628","volume":"112","author":"M Law","year":"2005","unstructured":"Law M, Morris JK, Jordan R, Wald N (2005) Headaches and the treatment of blood pressure: results from a meta-analysis of 94 randomized placebo-controlled trials with 24 000 participants. Circulation 112:2301\u20132306. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.104.529628","journal-title":"Circulation"},{"key":"1720_CR92","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/S11940-019-0556-3","volume":"21","author":"A Danesh","year":"2019","unstructured":"Danesh A, Gottschalk PCH (2019) Beta-blockers for migraine prevention: a review article. Curr Treat Options Neurol 21:20","journal-title":"Curr Treat Options Neurol"},{"issue":"6","key":"1720_CR93","doi-asserted-by":"publisher","first-page":"333102423118316","DOI":"10.1177\/03331024231183166","volume":"43","author":"C Carcel","year":"2023","unstructured":"Carcel C, Haghdoost F, Shen J et al (2023) The effect of blood pressure lowering medications on the prevention of episodic migraine: a systematic review and meta-analysis. Cephalalgia 43(6):3331024231183166. https:\/\/doi.org\/10.1177\/03331024231183166","journal-title":"Cephalalgia"},{"key":"1720_CR94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10072-010-0269-6","volume":"31","author":"P Barbanti","year":"2010","unstructured":"Barbanti P, Aurilia C, Egeo G, Fofi L (2010) Hypertension as a risk factor for migraine chronification. Neurol Sci 31:41. https:\/\/doi.org\/10.1007\/s10072-010-0269-6","journal-title":"Neurol Sci"},{"key":"1720_CR95","doi-asserted-by":"crossref","unstructured":"Farris SG, Thomas JG, Abrantes AM et al (2018) Intentional avoidance of physical activity in women with migraine. 1:251581631878828.","DOI":"10.1177\/2515816318788284"},{"key":"1720_CR96","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/NDT.S282565","volume":"17","author":"P Gazerani","year":"2021","unstructured":"Gazerani P (2021) A bidirectional view of migraine and diet relationship. Neuropsychiatr Dis Treat 17:435\u2013451. https:\/\/doi.org\/10.2147\/NDT.S282565","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1720_CR97","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/00002508-200503000-00006","volume":"21","author":"S Bruehl","year":"2005","unstructured":"Bruehl S, Ok YC, Jirjis JN, Biridepalli S (2005) Prevalence of clinical hypertension in patients with chronic pain compared to nonpain general medical patients. Clin J Pain 21:147\u2013153. https:\/\/doi.org\/10.1097\/00002508-200503000-00006","journal-title":"Clin J Pain"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01720-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01720-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:02:56Z","timestamp":1707091376000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01720-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1720"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01720-7","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]},"assertion":[{"value":"2 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate was not needed for this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed the final version and gave their approval for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}